Fundz

Aelius Biotech has raised £750K to enhance animal-free drug and food testing capabilities. The funding will support their growth in international markets, particularly in the US.

PRIVATEApr 07, 2025

Amount Raised

£750,000

Round Type

Seed

Newcastle Upon TyneBiotechnologyHealth Care

Investors

Mercia VenturesNorth East Venture Fund

Description

Aelius Biotech, a UK biotech company, has raised £750,000 from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures. This funding will enable the company to accelerate its growth in international markets, particularly in the US. Aelius Biotech provides innovative testing services that eliminate the need for animal testing. Their unique laboratory gut model effectively simulates the digestion process for improved product testing.

Quick answer

Aelius Biotech raised £750,000 in a Seed round, dated April 7, 2025. Investors: Mercia Ventures and North East Venture Fund. Aelius Biotech is based in Newcastle Upon Tyne, England, United Kingdom.

How much did Aelius Biotech raise?
Aelius Biotech raised £750,000 in a Seed round on April 7, 2025.
Who invested in Aelius Biotech?
Mercia Ventures and North East Venture Fund are named as investors in this round.
What does Aelius Biotech do?
Aelius Biotech is a UK biotech company that specializes in animal-free drug and food testing through its unique laboratory gut model.
Where is Aelius Biotech based and how big is it?
Aelius Biotech is based in Newcastle Upon Tyne, England, United Kingdom. Fundz records about 13 employees.
Who are the decision-makers at Aelius Biotech?
Fundz holds 1 contact at Aelius Biotech. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Aelius Biotech that raised within 45 days of this round, from Fundz verified event records.

  • Preve raised $2.2M (Seed) on May 22, 2025.
  • Entos Pharmaceuticals raised an undisclosed amount (Funding Round) on May 22, 2025.
  • WellTheory raised $5M (Funding Round) on May 22, 2025.
  • ReproNovo raised $65M (Series A) on May 21, 2025.
  • Betaliq raised $6M (Seed) on May 21, 2025.
  • 28bio raised $1.8M on May 21, 2025.

Who to call at Aelius Biotech, and when

A new round usually means Aelius Biotech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aelius Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aelius Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aelius Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aelius Biotech

Location

Newcastle Upon Tyne, England, United Kingdom

About

Aelius Biotech is a UK biotech company that specializes in animal-free drug and food testing through its unique laboratory gut model. This model allows for the simulation of all stages of the digestion process, providing vital insights for consumer health, pharmaceutical, and functional food companies. Founded in 2018, the company has quickly expanded its team and client base, achieving significant revenue growth in 2024.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aelius Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Aelius Biotech's next move

See what Strategic adds

Aelius Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.